[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369670-105":59,"doc-detail-369670-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","pgls-as-an-immune-and-prognostic-biomarker-from-pan-cancer-analysis-to-validation","PGLS as an immune and prognostic biomarker - from pan-cancer analysis to validation","","6-phosphogluconolactonase (PGLS), a metabolic enzyme in the pentose phosphate pathway, is linked to tumorigenesis, yet its pan-cancer role and clinical value remain unclear. This study defines PGLS expression across cancers using TCGA and GTEx mRNA-seq data, finding consistently higher levels in tumors than matched normal tissues and worse outcomes with high expression. PGLS correlates with immune regulatory genes, immune infiltration, heterogeneity, stemness, and anticancer drug sensitivity, and its knockdown suppresses Huh7 and A498 growth and invasion while shifting macrophage and T-cell populations toward an antitumor profile.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pgls-as-an-immune-and-prognostic-biomarker-from-pan-cancer-analysis-to-validation/369670/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pgls-as-an-immune-and-prognostic-biomarker-from-pan-cancer-analysis-to-validation/369670.png","ImageObject",300,407,{"name":92,"@type":93},"Đào","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main focus of this study on PGLS?","Question",{"text":112,"@type":113},"The study investigates PGLS expression patterns across multiple cancer types and evaluates its prognostic and immune-related associations, from pan-cancer analysis to validation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does PGLS expression relate to prognosis in cancers?",{"text":117,"@type":113},"Across cancers, PGLS expression is significantly higher in tumor tissues versus corresponding normal tissues, and high PGLS expression is linked to poor prognosis.",{"name":119,"@type":110,"acceptedAnswer":120},"What biological effects occur when PGLS is knocked down in cancer cells?",{"text":121,"@type":113},"PGLS knockdown slows growth and reduces migratory and invasive capacity in Huh7 and A498 cells, accompanied by an immune shift in the tumor microenvironment toward an antitumor phenotype.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369670,1790546236,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374402968488,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Lei et al. Discover Oncology (2025) 16:1316 [https://doi.org/10.1007/s12672-025-03108-8](https://doi.org/10.1007/s12672-025-03108-8)  \nDiscover Oncology  \nRESEARCH Open Access  \nPGLS as an immune and prognostic biomarker:  from pan-cancer analysis to validation  \nShiqiong Lei 1, Shaobo Hu2* and Weimin Wang2*  \n*Correspondence: Shaobo Hu[hsb9999@126.com](hsb9999@126.com)  \nWeimin Wang [wangweimin@hust.edu.cn](wangweimin@hust.edu.cn)[ ](wangweimin@hust.edu.cn)1Department of Thyroid and Breast Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China 2Liver Transplant Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Avenue, Wuhan 430022, Hubei, China  \nAbstract  \n6-phosphogluconolactonase (PGLS) is a metabolic enzyme of the pentose phosphate pathway that has been linked to tumorigenesis in several cancers. However, its role in pan-cancer remains unclear. This study reveals the expression profile and prognostic analysis of PGLS in different cancers by pan-cancer analysis. We utilized mRNA-seq data from TCGA and GTEx databases to analyze PGLS expression in different tumors. PGLS expression was significantly higher in almost all types of human cancer tissues compared to corresponding normal tissues. High PGLS expression was linked to poor prognosis. PGLS expression was significantly associated with immune regulatory genes, immune cell infiltration, tumor heterogeneity, tumor stemness, and involved in the regulation of anticancer drug sensitivity. Knockdown of PGLS resulted in slowed growth and diminished migratory and invasive capacity of Huh7 and A498 cells. Additionally, PGLS knockdown led to an increase in M1 macrophages, CD8+ T cells, and CD4+ T cells, while reducing the proportion of M2 macrophages and Tregsin tumor tissue. PGLS could serve as a potential therapeutic target and a reliable predictor of both prognostic factors and treatment sensitivity across various types of tumors. Further studies are warranted to explore its clinical application in cancer treatment.  \nKeywords Pentose phosphate pathway, 6-phosphogluconolactonase, Pancancer, Prognosis, Immune microenvironment  \n1 Introduction  \nCancer continues to pose a significant global health threat, accounting for approximately one sixth of all deaths annually worldwide [1, 2]. Despite advancements in clinical treatment and basic medical research, the possibility of achieving a cure for cancer remains elusive. However, recent developments in targeted combination immunotherapy regimens have shown promise in improving survival rates for certain cancer patients [3–6]. As the need for more personalized therapeutic strategies grows, leveraging big data to identify novel and effective targets has become a critical avenue of research. One such approach is pan-cancer analysis, which has gained traction as a powerful tool for uncovering broader patterns in cancer biology and treatment response.Through pan-cancer analysis, it is anticipated that key intersections in cancer-targeted immunotherapy  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you w","cbCaidn7iLRJOH2G","https://ap.wps.com/l/cbCaidn7iLRJOH2G","pdf",10693779,22,"English","# Introduction\n## Pan-cancer strategy and personalized therapy\n## Metabolic transformation and PPP in cancer\n## PGLS in PPP and cancer progression","[{\"question\":\"What is the main focus of this study on PGLS?\",\"answer\":\"The study investigates PGLS expression patterns across multiple cancer types and evaluates its prognostic and immune-related associations, from pan-cancer analysis to validation.\"},{\"question\":\"How does PGLS expression relate to prognosis in cancers?\",\"answer\":\"Across cancers, PGLS expression is significantly higher in tumor tissues versus corresponding normal tissues, and high PGLS expression is linked to poor prognosis.\"},{\"question\":\"What biological effects occur when PGLS is knocked down in cancer cells?\",\"answer\":\"PGLS knockdown slows growth and reduces migratory and invasive capacity in Huh7 and A498 cells, accompanied by an immune shift in the tumor microenvironment toward an antitumor phenotype.\"}]","PGLS as an immune and prognostic biomarker - from pan-cancer analysis to validation | PDF",1790184006,55,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/95d83d26f90ae9604637557af4c092d9.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ba00583ca55e172b05b23d396d73d6a8.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fb981887b9e93369e2dd2e328b55ed2b.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f05f943b14df88286897dbe431af086f.webp",980,1306]